Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.0.8
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Statements Of Operations [Abstract]        
Revenue            
Operating expenses:        
Research and development, net of reimbursements 2,001,937 509,262 4,462,905 1,594,968
General and administrative 2,414,627 966,367 4,090,680 1,899,503
Depreciation expense 8,052    9,457   
Loss on disposition of equipment          4,122
Total operating expenses 4,424,616 1,475,629 8,563,042 3,498,593
Loss from operations (4,424,616) (1,475,629) (8,563,042) (3,498,593)
Other income (expense):        
Interest expense    (634)    (1,209)
Gain (loss) on change in fair value of derivative liabilities 7,939,711 (1,307,748) (4,621,360) 26,764
Total other income and (expense) 7,939,711 (1,308,382) (4,621,360) 25,555
Net income (loss) $ 3,515,095 $ (2,784,011) $ (13,184,402) $ (3,473,038)
Net income (loss) per common share - basic $ 0.14 $ (0.13) $ (0.52) $ (0.16)
Net income (loss) per common share - diluted $ 0.10 $ (0.13) $ (0.52) $ (0.16)
Weighted average common shares outstanding - basic 25,795,573 22,178,637 25,513,505 21,791,673
Weighted average common shares outstanding - diluted 35,862,173 22,178,637 25,513,505 21,791,673